A

Aquestive Therapeutics
D

AQST

4.15000
USD
-0.06
(-1.31%)
مغلق
حجم التداول
30,246
الربح لكل سهم
-1
العائد الربحي
-
P/E
-7
حجم السوق
412,210,901
أصول ذات صلة
A
ACRE
0.06500
(1.42%)
4.65500 USD
A
ADMA
0.710
(4.10%)
18.020 USD
ALNY
ALNY
1.29
(0.39%)
329.01 USD
A
ANIP
0.560
(0.84%)
67.500 USD
A
ARWR
-0.520
(-3.20%)
15.740 USD
A
AXSM
-4.200
(-4.00%)
100.830 USD
B
BCRX
0.00000
(0.00%)
8.55500 USD
B
BHC
0.00000
(0.00%)
6.78000 USD
C
CRBP
0.18000
(2.00%)
9.17000 USD
المزيد
الأخبار المقالات

العنوان: Aquestive Therapeutics

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.